BioRestorative Therapies, Inc. ( BRTX) - Stock Earnings
BRTX Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 11, 2026, midnight | — / — | — | — / — | — |
BRTX Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -3.0 million USD | 11800 USD |
| 2025Q4 | -3.2 million USD | 19600 USD |
| 2026Q1 | -2.2 million USD | 23170 USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
BRTX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -10.4 million USD | 145800 USD |
| 2024 | -9.0 million USD | 401000 USD |
| 2025 | -14.2 million USD | 359700 USD |
| 2026 Est. | — | — |
BRTX
Price: $1.62
Earnings Per Share: -21.40 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 19500
Market Capitalization: 2.6 million